Vinflunine
62 interactions 4 explained in plain English
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Eribulin Injection
Hydroxychloroquine
Oxaliplatin Injection
Ofloxacin
Amisulpride Injection
Ivabradine
Major
Vinflunine Amitriptyline Elavil Explained Increased risk of QT-interval prolongation Details Vinflunine Sertraline Explained An increased risk of QT interval prolongation Details Vinflunine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Vinflunine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Vinflunine Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Vinflunine Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation Details Vinflunine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Vinflunine Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation Details Vinflunine Asenapine Transdermal Patch Secuado Increased risk of QT-interval prolongation Details Vinflunine Azithromycin AzaSite Increased risk of QT-interval prolongation Details Vinflunine Alfuzosin UroXatral Increased risk of QT-interval prolongation Details Vinflunine Anagrelide Agrylin Increased risk of QT-interval prolongation Details Vinflunine Bedaquiline Sirturo Increased risk of QT-interval prolongation Details Vinflunine Chloroquine Aralen® Increased risk of QT-interval prolongation Details Vinflunine Dasatinib Phyrago Increased risk of QT-interval prolongation Details Vinflunine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Vinflunine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Vinflunine Disopyramide Norpace Increased risk of QT-interval prolongation Details Vinflunine Dofetilide Tikosyn Increased risk of QT-interval prolongation Details Vinflunine Dolasetron Anzemet Increased risk of QT-interval prolongation Details Vinflunine Dolasetron Injection Anzemet Increased risk of QT-interval prolongation Details Vinflunine Encorafenib Braftovi Increased risk of QT interval prolongation Details Vinflunine Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Vinflunine Eribulin Injection Halaven Increased risk of QT-interval prolongation Details Vinflunine Famotidine Calmicid Increased risk of QT-interval prolongation Details Vinflunine Famotidine Injection Calmicid Increased risk of QT-interval prolongation Details Vinflunine Felbamate Felbatol Increased risk of QT-interval prolongation Details Vinflunine Flecainide Tambocor® Increased risk of QT-interval prolongation Details Vinflunine Foscarnet Injection Foscavir Increased risk of QT-interval prolongation Details Vinflunine Fostemsavir Rukobia Increased risk of torsade de pointes Details Vinflunine Galantamine Razadyne Increased risk of QT-interval prolongation Details Vinflunine Gatifloxacin Ophthalmic Zymar® Increased risk of QT-interval prolongation Details Vinflunine Gemifloxacin Factive Increased risk of QT-interval prolongation Details Vinflunine Glasdegib Daurismo Increased risk of QT interval prolongation Details Vinflunine Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Vinflunine Granisetron Transdermal Patch Sancuso Increased risk of QT-interval prolongation Details Vinflunine Granisetron Injection Granisol Increased risk of QT-interval prolongation Details Vinflunine Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Vinflunine Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Vinflunine Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.